Skip to main content
Equibles

Moran Wealth Management, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1965334 Naples, FL
Back to REGN Full portfolio

Position in REGN

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$2,681,221
-$716,849 QoQ
Shares Held
4,300
-2.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#479
of 1,329 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 98% Shared 2% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Moran Wealth Management, LLC holds $37,590,704 across 10 Biotechnology names. REGN ranks #5 (7.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 186,672 $10,466,698
2 EXEL
Exelixis, Inc.
 141,150 $7,679,970
3 HALO
Halozyme Therapeutics, Inc.
 80,381 $6,291,420
4 LGND
Ligand Pharmaceuticals Inc
 19,790 $6,255,420
5 REGN
Regeneron Pharmaceuticals, Inc.
This page 		4,300 $2,681,221
6 CRSP
CRISPR Therapeutics AG
 35,374 $1,929,297
7 STOK
Stoke Therapeutics, Inc.
 47,977 $1,569,807
8 RNA
Atrium Therapeutics, Inc.
 33,320 $448,154

All Filings in REGN

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,681,221 4,300
2026-03-31 $3,398,070 4,398
2025-12-31 $3,550,601 4,600
2025-09-30 $2,530,777 4,501
2025-06-30 $2,409,750 4,590
2025-03-31 $12,558,388 19,801
2024-12-31 $14,017,229 19,678
2024-09-30 $23,354,347 22,216
2024-06-30 $20,646,433 19,644
2024-03-31 $19,340,274 20,094
2023-12-31 $18,023,389 20,521
2023-09-30 $16,893,722 20,528
2023-06-30 $14,974,373 20,840
2023-03-31 $17,735,746 21,585
2022-12-31 $15,862,679 21,986